Literature DB >> 16289204

Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist).

Zhongying Chen1, Amy Aspelund, George Kemble, Hong Jin.   

Abstract

Cold adapted (ca) B/Ann Arbor/1/66 is the master donor virus for the influenza B (MDV-B) vaccine component of the live attenuated influenza vaccine (FluMist). The six internal genes contributed by MDV-B confer the characteristic cold-adapted (ca), temperature-sensitive (ts) and attenuated (att) phenotypes to the vaccine strains. Previously, it has been determined that the PA and NP segments of MDV-B control the ts phenotype while the att phenotype requires the M segment in addition to PA and NP. Here, we show that the PA, NP and PB2 segments are responsible for the ca phenotype of MDV-B when examined in chicken cell lines. Five loci in three RNA segments, R630 in PB2, M431 in PA and A114, H410 and T509 in NP, are sufficient to allow efficient virus growth at 25 degrees C. Substitution of these five amino acids with wt (wild type) residues completely reverted the MDV-B ca phenotype. Conversely, introduction of these five ca amino acids into B/Yamanashi/166/98 imparted the ca phenotype to this heterologous wt virus. In addition, we also found that the MDV-B M1 gene affected virus replication in chicken cells at 33 and 37 degrees C. Recombinant viruses containing the two MDV-B M1 residues (Q159, V183) replicated less efficiently than those containing wt M1 residues (H159, M183) at 33 and 37 degrees C, implicating the role of the MDV-B M segment to the att phenotype. The complexity of the multigenic signatures controlling the ca, ts and att phenotypes of MDV-B provides the molecular basis for the observed genetic stability of the FluMist vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289204     DOI: 10.1016/j.virol.2005.10.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines.

Authors:  Yuk-Fai Lau; Celia Santos; Fernando J Torres-Vélez; Kanta Subbarao
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

Review 2.  The evolution of nasal immune systems in vertebrates.

Authors:  Ali Sepahi; Irene Salinas
Journal:  Mol Immunol       Date:  2015-09-19       Impact factor: 4.407

3.  Haemagglutinin substitutions N125D, D127E, D222G and R223Q improve replicative fitness and vaccine effectiveness of an A/H1N1pdm09 live attenuated influenza vaccine virus by enhancing α-2,6 receptor binding.

Authors:  Rachael Dempsey; Giulia Tamburrino; Katarzyna E Schewe; Jonathan Crowe; Annalisa Nuccitelli; Oliver Dibben
Journal:  PLoS Pathog       Date:  2022-05-27       Impact factor: 7.464

4.  Characterization of the nucleocytoplasmic shuttle of the matrix protein of influenza B virus.

Authors:  Shuai Cao; Jingwen Jiang; Jing Li; Yan Li; Limin Yang; Shanshan Wang; Jinghua Yan; George F Gao; Wenjun Liu
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

5.  Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferrets.

Authors:  Zhongying Chen; Celia Santos; Amy Aspelund; Laura Gillim-Ross; Hong Jin; George Kemble; Kanta Subbarao
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

6.  A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine.

Authors:  Hiroaki Katsura; Kiyoko Iwatsuki-Horimoto; Satoshi Fukuyama; Shinji Watanabe; Saori Sakabe; Yasuko Hatta; Shin Murakami; Masayuki Shimojima; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  Vaccine       Date:  2012-08-03       Impact factor: 3.641

7.  A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine.

Authors:  Xiangmin Zhang; Wei Kong; Shamaila Ashraf; Roy Curtiss
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

8.  Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid.

Authors:  Xiangmin Zhang; Roy Curtiss
Journal:  Virol J       Date:  2015-06-22       Impact factor: 4.099

9.  Generation of influenza virus from avian cells infected by Salmonella carrying the viral genome.

Authors:  Xiangmin Zhang; Wei Kong; Soo-Young Wanda; Wei Xin; Praveen Alamuri; Roy Curtiss
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

Review 10.  Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.

Authors:  Christopher S Ambrose; Catherine Luke; Kathleen Coelingh
Journal:  Influenza Other Respir Viruses       Date:  2008-11       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.